A recent study suggests that patients who come off new weight-loss injections like Mounjaro or Wegovy can put back on shed pounds far faster than those who halt conventional lifestyle plans.
Findings released in a major health publication shows that while overweight individuals frequently drop substantial amounts of their body weight while undergoing treatment, the weight returns at an estimated rate of 0.8 kg per month once they quit.
"People purchasing such treatments should be aware of the potential of fast weight regain when the medication concludes," cautioned lead investigator Dr. Susan Jebb.
Such speed of recovery implies a reversion to original weight in about a year and a half.
Analyzing Therapies
The analysis, which examined dozens of trials involving thousands of participants, compared the results of GLP-1 agonists with other pills.
Researchers point out that people who lose weight through dieting generally experience a slower weight regain—around 0.1 kg a month—once they finish.
Explaining the Rapid Regain
Experts propose the way of the injections is key to understanding the heightened weight return.
GLP-1 drugs copy a natural hormone called GLP-1, which helps regulate appetite.
"Artificially providing GLP-1 concentrations far above than the body's typical production might result in the body to generate a reduced amount of its own natural GLP-1, and may also lessen responsiveness to its actions," said Dr. Adam Collins, a nutrition researcher.
"Withdrawal of this hormone supplement means appetite is uncontrolled, making excessive eating a significant risk."
A Lifelong Condition?
Health authorities advise the injections for people with weight-linked health risks, alongside prescribed diet and exercise modifications.
A number of clinicians contend that, due to the high risk of relapse, the therapy might need to be ongoing.
This opinion is echoed by pharmaceutical companies, who note that the results "highlight the long-term nature of excess weight," comparing it to managing conditions like hypertension.
Patient Experiences
Users who have stopped the medication report a sudden resurgence of hunger.
"It felt as if a switch activating and I was suddenly extremely hungry," recalled one woman.
This difficulty is worsened if users have not developed permanent lifestyle or habit changes during treatment.
Widespread Adoption
Recent estimates show that millions of adults in the UK have used weight-loss jabs in the past year, with desire being substantial.
- Adoption is greater among females compared to males.
- The middle-aged age group shows the greatest usage rates.
- A large proportion obtain the medications through private prescriptions rather than public health services.
In conclusion, clinicians stress that while GLP-1 drugs are effective agents for weight loss, they are not a permanent cure and lasting health benefits relies on combined lifestyle changes.
